[HTML][HTML] Efficacy and safety of eslicarbazepine acetate as a first or later adjunctive therapy in patients with focal seizures
Introduction We report outcomes from an open-label, non-randomized, 24-week study of
eslicarbazepine acetate (ESL) in adults at earlier and later stages of their treatment history …
eslicarbazepine acetate (ESL) in adults at earlier and later stages of their treatment history …
Efficacy and safety of eslicarbazepine acetate as a first or later adjunctive therapy in patients with focal seizures
J Hixson, B Gidal, A Pikalov, Y Zhang… - Epilepsy …, 2021 - pubmed.ncbi.nlm.nih.gov
Introduction We report outcomes from an open-label, non-randomized, 24-week study of
eslicarbazepine acetate (ESL) in adults at earlier and later stages of their treatment history …
eslicarbazepine acetate (ESL) in adults at earlier and later stages of their treatment history …
Efficacy and safety of eslicarbazepine acetate as a first or later adjunctive therapy in patients with focal seizures
J Hixson, B Gidal, A Pikalov, Y Zhang, D Mehta, D Blum… - 2021 - escholarship.org
IntroductionWe report outcomes from an open-label, non-randomized, 24-week study of
eslicarbazepine acetate (ESL) in adults at earlier and later stages of their treatment history …
eslicarbazepine acetate (ESL) in adults at earlier and later stages of their treatment history …
Efficacy and safety of eslicarbazepine acetate as a first or later adjunctive therapy in patients with focal seizures.
J Hixson, B Gidal, A Pikalov, Y Zhang, D Mehta… - Epilepsy …, 2021 - europepmc.org
Methods ESL was taken as the first adjunctive therapy to levetiracetam (LEV) or lamotrigine
(LTG) monotherapy (Arm 1), or as a later adjunctive therapy in treatment-resistant patients …
(LTG) monotherapy (Arm 1), or as a later adjunctive therapy in treatment-resistant patients …